Charles River Laboratories International Earnings

Charles River Laboratories International’s revenue fell -0.49% since last year same period to $1004.85Mn in the Q3 2025. On a quarterly growth basis, Charles River Laboratories International has generated -2.64% fall in its revenue since last 3-months.

Charles River Laboratories International’s net profit fell -20.76% since last year same period to $54.42Mn in the Q3 2025. On a quarterly growth basis, Charles River Laboratories International has generated 4.01% jump in its net profits since last 3-months.

Charles River Laboratories International’s net profit margin fell -20.37% since last year same period to 5.42% in the Q3 2025. On a quarterly growth basis, Charles River Laboratories International has generated 6.83% jump in its net profit margins since last 3-months.

Charles River Laboratories International’s earning per share (EPS) estimates for the current quarter stand at 2.35 - a -7.84% fall from last quarter’s estimates.

Charles River Laboratories International’s earning per share (EPS) estimates for the current year stand at 2.35.

Charles River Laboratories International’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Charles River Laboratories International has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.